TOP TIERMARKET NEWSWIRE
News & sentiment

AGOMAB THERAPEUTICS ADR (AGMB) — News & AI sentiment

AGOMAB THERAPEUTICS ADR (AGMB) news roundup. 2 stories in the past week, 6 over 30 days. Average 30-day sentiment is 56.2/100. Recent insider activity (SEC Form 4, 90-day window): 5 purchases totalling $400K and 0 sales totalling $0 — net buying of $400K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 51/100
30d stories
6
avg sentiment 56.2/100
Insider net (90d)
$400K
5 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

AGMB news in the last 24 hours, 7 days, 30 days and 90 days

How much AGMB coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAGMB storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days251/100AGMB headlines →
Last 30 days656.2/100AGMB headlines →
Last 90 days2358.4/100AGMB headlines →

Latest stories on AGMB

Agomab to Participate in Upcoming Investor Conferences
Business Insider52 · neutralproduct/pr
2d ago
Agomab Therapeutics NV trading resumes
The Fly50 · neutralgeneral
7d ago
Agomab Therapeutics stock rating reiterated at Buy by H.C. Wainwright
Investing.com Analyst Ratings61 · neutralanalyst
Oct 21
Oct 13
Oct 13
Oct 8
H.C. Wainwright reiterates Agomab stock rating on trial data
Investing.com Analyst Ratings56 · neutralanalyst
Oct 2
Oct 1
Why is Agomab Therapeutics stock sliding today?
Investing.com Markets34 · bearishgeneral
Oct 1
Agomab stock jumps on positive trial data
Investing.com Markets73 · bullishproduct/pr
Oct 1
Oct 1
Oct 1
Sep 16
Sep 14
Sep 14
Sep 11
Sep 11
Sep 3
Agomab to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Sep 3
Aug 25
Piper Sandler initiates Agomab stock with Overweight rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 25
Aug 19
Aug 10
AgomAb Therapeutics NV reports 1H results
Seeking Alpha48 · neutralearnings
Aug 7
Aug 6
Open AGMB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →